NIH Obesity Research Funding Opportunities

Current Funding Opportunities

1. Posted: Oct. 27, 2020

   Notice of Intent to Publish a Funding Opportunity Announcement for Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) Multisite (UG3/UH3) with Coordinating Center (U24)

   NOT-HL-20-820
2. Posted: July 23, 2020

   Notice of Special Interest (NOSI): Improving Methods to Assess Body Composition in Infants and Young Children

   NOT-DK-20-036
3. Posted: July 13, 2020

   Notice of Special Interest (NOSI): Obesity Policy Evaluation Research (R01 Clinical Trial Not Allowed)

   NOT-DK-20-035
4. Posted: April 13, 2020

   Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences

   NOT-OD-20-097
5. Posted: March 11, 2020

   Gastrointestinal (GI) and Microbiome Explorers: Development of Swallowable Smart Pills or Devices for Precision Nutrition, Microbiome and Digestive Disease Applications (R21/R33 Clinical Trial Required)

   PAR-20-133
6. Posted: March 11, 2020

   Development of Wearable Smart Devices for Continuous Monitoring of Circulating Nutrients, Metabolites and Hormones (R21/R33 Clinical Trial Required)

   PAR-20-134
7. Posted: Sept. 16, 2019

   Bioinformatics Interdisciplinary Predoctoral Fellowship in Diabetes, Endocrinology and Metabolic Diseases (F31)

   PAR-19-378
8. Posted: Sept. 16, 2019

   Bioinformatics Interdisciplinary Postdoctoral Fellowship in Diabetes, Endocrinology and Metabolic Diseases (F32)

   PAR-19-379
9. Posted: May 21, 2019

   Notice of Special Interest (NOSI): Understanding Factors in Infancy and Early Childhood (Birth to 24 months) That Influence Obesity Development 

   NOT-HL-19-695
10. Posted: March 13, 2019

    Silvio O. Conte Digestive Diseases Research Core Centers (P30 Clinical Trial Optional) 

    RFA-DK-19-004
11. Posted: Jan. 7, 2019

    Notice of Special Interest in Understanding Factors in Infancy and Early Childhood (Birth to 24 months) That Influence Obesity Development 

    NOT-DK-19-007
12. Posted: Aug. 9, 2018

    Elucidating the Role of the Autonomic Nervous System in Peripheral Metabolism and Metabolic Disease through the Application of Novel Tools and Methodologies (RC2 Clinical Trial Optional)

    PAR-18-898
13. Posted: Aug. 7, 2018

    Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01 Clinical Trial Optional) 

    PAR-18-893
14. Posted: Aug. 7, 2018

    Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21 Clinical Trial Optional)

    PAR-18-892
15. Posted: Aug. 2, 2018

    New Paradigms in Tissue Communication-from mediators to metabolic function (RC2 Clinical Trials Optional)

    PAR-18-886
16. Posted: July 17, 2018

    Diet and Physical Activity Assessment Methodology (R21 Clinical Trial Not Allowed) 

    PAR-18-857
17. Posted: July 17, 2018

    Diet and Physical Activity Assessment Methodology (R01 Clinical Trial Not Allowed) 

    PA-18-856
18. Posted: July 12, 2018

    Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed) 

    PAR-18-854
19. Posted: May 15, 2018

    The Mechanistic Role of the Microbiome in the Pathobiology of Heart, Lung, Blood, and Sleep Diseases (R01 - Clinical Trial Not Allowed) 

    PA-18-784
20. Posted: May 9, 2018

    Maternal Nutrition and Pre-pregnancy Obesity: Effects on Mothers, Infants and Children (R01 Clinical Trial Optional)

    PA-18-776
21. Posted: April 3, 2018

    Secondary Analyses in Obesity, Diabetes and Digestive and Kidney Diseases (R21 Clinical Trial Not Allowed) 

    PA-18-741